These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 10817540

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action.
    Page ME, Brown K, Lucki I.
    Psychopharmacology (Berl); 2003 Jan; 165(2):194-201. PubMed ID: 12426668
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of repeated treatment with reboxetine on the central alpha 1-adrenergic and dopaminergic receptors.
    Rogóz Z, Margas W, Skuza G, Solich J, Kuśmider M, Dziedzicka-Wasylewska M.
    Pol J Pharmacol; 2002 Jan; 54(6):593-603. PubMed ID: 12866714
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Repeated trimipramine induces dopamine D2/D3 and alpha1-adrenergic up-regulation.
    Maj J, Rogóz Z, Skuza G, Margas W.
    J Neural Transm (Vienna); 1998 Jan; 105(2-3):329-42. PubMed ID: 9660111
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Norzotepine, a major metabolite of zotepine, exerts atypical antipsychotic-like and antidepressant-like actions through its potent inhibition of norepinephrine reuptake.
    Shobo M, Kondo Y, Yamada H, Mihara T, Yamamoto N, Katsuoka M, Harada K, Ni K, Matsuoka N.
    J Pharmacol Exp Ther; 2010 Jun; 333(3):772-81. PubMed ID: 20223878
    [Abstract] [Full Text] [Related]

  • 17. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M, Dekeyne A, Papp M, Millan MJ.
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The central action of salbutamol, a beta-agonist with a potential antidepressant activity.
    Przegalinski E, Baran L, Kedrek G.
    Pol J Pharmacol Pharm; 1980 Nov; 32(4):485-93. PubMed ID: 6265886
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.